Obesity Management Market by Prescription (Weight-loss Medication (orlistat, lorcaserin, phentermine); by Surgery; by Lifestyle changes - Forecast to 2022

PUNE, MAHARASHTRA, INDIA, July 13, 2017 /EINPresswire.com/ -- Market Highlights
The Global Obesity Management Market has been evaluated as steadily growing market and it is expected that the market will continue to grow similarly in the near future. Obesity occurs due to energy imbalance between calories intake and calories expanded. Obesity affects health and can lead to various diseases like heart diseases, stroke, diabetes, hypertension etc. Changing lifestyle such as eating junk food or energy dense food that are high percentage of fat, low physical activity are the major factors that leads to obesity. The population of obese people has doubled since 1980. According to World Health Organization (WHO), in 2014, more than 1.9 billion adults, 18 years and older, were overweight. Out of these over 600 million were obese and about 39% of adults were underweight and out of these 13% were obese. Most of the countries of the World are facing the problem of obesity. Earlier high income countries were facing the problem of obesity and overweight but now problem of obesity is on rise in low and middle income countries. Obesity can be prevented by some dietary changes and exercise. Consumers are becoming more conscious about their health which is driving the growth for the obesity management market. Drugs manufacturers spending money in R&D to develop new drugs and supplements. Healthcare solution provider companies are also providing advance solutions for hospitals. Global Obesity Management Market was about US$ 4.17 billion in 2015 and is expected to reach US$ 6.2 billion by 2022 at a CAGR of 8.2%.

Request a Sample Copy @ https://www.marketresearchfuture.com/sample_request/2690

Key Players for Obesity Management Market:
• Pfizer Inc. (US),
• Merck Sharp & Dohme Corp.,
• a subsidiary of Merck & Co., Inc. (US),
• F. Hoffmann-La Roche Ltd (Switzerland),
• GlaxoSmithKline plc. (UK),
• AstraZeneca (UK),
• Herbalife Ltd. (U.S.),
• Apollo Endosurgery (U.S.),
• Ethicon, Inc. (U.S.)

Commenting on the report, an analyst from Market Research Future (MRFR)’s team said: The market for Obesity Management is growing moderately and expected to continue its growth similarly in near future. Obesity and overweight occurs due to energy imbalance between calories consumed and calories distributed in body. Physical inactivity and no exercise leads to obesity and overweight. Obesity can create many medical complications such as high blood pressure, heart attack and other heart related diseases and diabetes. According to report of World Health Organization (WHO), 41 million children under the age of 5 were overweight or obese and 600 million adults were obese in 2014. Few decades ago, obesity was limited to developed nations but now the population of obese people are rapidly increasing in low and middle income developing nations. New drugs and supplement development, technological advanced medical solutions and increasing medical facilities are leading the market growth for obesity management. Increasing customer awareness regarding health is encouraging fitness equipment manufacturers to create more advanced and useful equipment for exercise. Global Obesity Management Market was around US$ 4.17 billion in 2015 while it is expected to reach USD 6.2 billion by 2022 at a CAGR of 8.2% during the forecast period. There are some factors that are inhibiting the growth of the market such as side effects of drugs, high cost of surgeries, lack of knowledge about disorder, misinformation about weight loss products etc.

Taste the market data and market information presented through more than 50 market data tables and figures spread in 110 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Obesity Management Market Research Report- Global Forecast to 2022”

Browse full report @ https://www.marketresearchfuture.com/reports/obesity-management-market

Segments:
Obesity Management Market has been segmented
On the basis of Prescription weight-loss medication which comprise orlistat (Xenical), lorcaserin (Belviq), phentermine and topiramate (Qsymia), buproprion and naltrexone (Contrave), and liraglutide (Saxenda), and others.
On the basis of Surgery it segmented into Gastric bypass surgery, Laparoscopic adjustable gastric banding (LAGB), Biliopancreatic diversion with duodenal switch, and others.
On the basis of lifestyle changes it is segmented into Dietary changes, Exercise, and others.

Table of Content

1. Report Prologue
2. Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
2.3 Market Structure
2.4. Market Segmentation
3. Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Mega Trends
4.5 Macroeconomic Indicators
5. Market Factor Analysis
Continue………..

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact:
Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com

Akash Anand
Market Research Future
+1-646-845-9349 (US) / +44 208 133 9349 (UK)
email us here